Literature DB >> 23041273

Aldosterone and angiotensin: Role in diabetes and cardiovascular diseases.

Bhoomika M Patel1, Anita A Mehta.   

Abstract

The present review shall familiarize the readers with the role of renin-angiotensin aldosterone system (RAAS), which regulates blood pressure, electrolyte and fluid homeostasis. The local RAAS operates in an autocrine, paracrine and/or intracrine manner and exhibits multiple physiological effects at the cellular level. In addition to local RAAS, there exists a complete pancreatic RAAS which has multi-facet role in diabetes and cardiovascular diseases. Aldosterone is known to mediate hyperinsulinemia, hypertension, cardiac failure and myocardial fibrosis while angiotensin II mediates diabetes, endothelial dysfunction, vascular inflammation, hypertrophy and remodeling. As the understanding of this biology of RAAS increases, it serves to exploit this for the pharmacotherapy of diabetes and cardiovascular diseases.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23041273     DOI: 10.1016/j.ejphar.2012.09.034

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  29 in total

Review 1.  The (pro)renin receptor and body fluid homeostasis.

Authors:  Theresa Cao; Yumei Feng
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-05-15       Impact factor: 3.619

2.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

Review 3.  New agents modulating the renin-angiotensin-aldosterone system-Will there be a new therapeutic option?

Authors:  Anna Gromotowicz-Poplawska; Piotr Szoka; Patrycjusz Kolodziejczyk; Karol Kramkowski; Marzena Wojewodzka-Zelezniakowicz; Ewa Chabielska
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-19

4.  Long-term treatment of spontaneously hypertensive rats with PD123319 and electrophysiological remodeling of left ventricular myocardium.

Authors:  Xiao Ying; Guan Kai-Pan; Long Wei-Qing; Peng Long-Yun; Wu De-Xi; Huang Zhi-Bin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-09-14       Impact factor: 3.000

Review 5.  Dysfunctional brain-bone marrow communication: a paradigm shift in the pathophysiology of hypertension.

Authors:  Monica M Santisteban; Jasenka Zubcevic; David M Baekey; Mohan K Raizada
Journal:  Curr Hypertens Rep       Date:  2013-08       Impact factor: 5.369

6.  Identification of a missense variant in LNPEP that confers psoriasis risk.

Authors:  Hui Cheng; Yang Li; Xian-Bo Zuo; Hua-Yang Tang; Xian-Fa Tang; Jin-Ping Gao; Yu-Jun Sheng; Xian-Yong Yin; Fu-Sheng Zhou; Chi Zhang; Gang Chen; Jun Zhu; Qian Pan; Bo Liang; Xiao-Dong Zheng; Pan Li; Yan-Tao Ding; Fang Cheng; Jing Luo; Rui-Xue Chang; Gong-Bu Pan; Xing Fan; Zai-Xing Wang; An-Ping Zhang; Jian-Jun Liu; Sen Yang; Liang-Dan Sun; Xue-Jun Zhang
Journal:  J Invest Dermatol       Date:  2013-07-29       Impact factor: 8.551

7.  Synergistic effects of high blood cholesterol and hypertension on leukocyte and platelet recruitment in the cerebral microcirculation.

Authors:  Stephen F Rodrigues; Lidiana D Almeida-Paula; Daniel N Granger
Journal:  Hypertension       Date:  2013-12-30       Impact factor: 10.190

8.  Two-Year Outcomes of Patients Treated With Aliskiren Under Clinical Practice Conditions: Non-Interventional Prospective Study.

Authors:  Uwe Zeymer; Ralf Dechend; Thomas Riemer; Evelin Deeg; Jochen Senges; David Pittrow; Roland Schmieder
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-11-14       Impact factor: 3.738

9.  Effects of Vitamin D Supplementation on Plasma Aldosterone and Renin-A Randomized Placebo-Controlled Trial.

Authors:  Martin R Grübler; Martin Gaksch; Katharina Kienreich; Nicolas Verheyen; Johannes Schmid; Bríain W J Ó Hartaigh; Georg Richtig; Hubert Scharnagl; Andreas Meinitzer; Burkert Pieske; Astrid Fahrleitner-Pammer; Winfried März; Andreas Tomaschitz; Stefan Pilz
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-04-21       Impact factor: 3.738

Review 10.  NRF2 in Cardiovascular Diseases: a Ray of Hope!

Authors:  Ruju Vashi; Bhoomika M Patel
Journal:  J Cardiovasc Transl Res       Date:  2020-11-25       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.